Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenjun Wu

Showing results (441-450 of 455) with videos related to

Pageof 46
Sort By:
Bone Marrow Transplantation|August 7, 2019
Quantitative characterization of T-cell repertoire alteration in Chinese patients with B-cell acute lymphocyte leukemia after CAR-T therapyXiujian Wang, Yongxian Hu, Xiao Liu, et al.
Cancers|January 10, 2026
15-Day Duration of Venetoclax Combined with Azacitidine in Treatment-Naive Higher-Risk Myelodysplastic Syndromes: A Prospective Multicenter StudyBinbin Lai, Chen Mei, Xiao Yan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 5, 2020
Single-Cell Transcriptomic Analysis Reveals BCMA CAR-T Cell Dynamics in a Patient with Refractory Primary Plasma Cell LeukemiaXue Li, Xin Guo, Yuqing Zhu, et al.
JAMA Oncology|April 17, 2025
Dasatinib and CAR T-Cell Therapy in Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Nonrandomized Clinical TrialMingming Zhang, Shan Fu, Jingjing Feng, et al.
Science Translational Medicine|February 25, 2021
Radiotherapy and immunotherapy converge on elimination of tumor-promoting erythroid progenitor cells through adaptive immunityYuzhu Hou, Hua L Liang, Xinshuang Yu, et al.
BMC Immunology|April 6, 2025
Prediction of Seronegative Hashimoto's thyroiditis using machine learning models based on ultrasound radiomics: a multicenter studyWenjun Wu, Shengsheng Yao, Daming Liu, et al.
JAMA Internal Medicine|November 3, 2025
Liraglutide in Acute Minor Ischemic Stroke or High-Risk Transient Ischemic Attack With Type 2 Diabetes: The LAMP Randomized Clinical TrialHuili Zhu, Bin Yang, Longyan Lu, et al.
American Journal of Hematology|September 20, 2023
Comparison of the prognostic predictive value of Molecular International Prognostic Scoring System and Revised International Prognostic Scoring System in patients undergoing allogeneic hematopoietic stem cell transplantation for myelodysplastic neoplasmsTingting Yang, Binqian Jiang, Yi Luo, et al.
Bone Marrow Transplantation|December 3, 2024
Better pre-transplant treatment options for TP53-mutated MDS: cytoreductive or non-cytoreductive therapy?Bingqian Jiang, Tingting Yang, Yanmin Zhao, et al.
Journal of Hematology & Oncology|May 6, 2020
Pre-transplant MRD negativity predicts favorable outcomes of CAR-T therapy followed by haploidentical HSCT for relapsed/refractory acute lymphoblastic leukemia: a multi-center retrospective studyHouli Zhao, Jieping Wei, Guoqing Wei, et al.
Pageof 46

Showing results (441-450 of 455) with videos related to

Sort By:
Pageof 46
Bone Marrow Transplantation|August 7, 2019
Quantitative characterization of T-cell repertoire alteration in Chinese patients with B-cell acute lymphocyte leukemia after CAR-T therapyXiujian Wang, Yongxian Hu, Xiao Liu, et al.
Cancers|January 10, 2026
15-Day Duration of Venetoclax Combined with Azacitidine in Treatment-Naive Higher-Risk Myelodysplastic Syndromes: A Prospective Multicenter StudyBinbin Lai, Chen Mei, Xiao Yan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 5, 2020
Single-Cell Transcriptomic Analysis Reveals BCMA CAR-T Cell Dynamics in a Patient with Refractory Primary Plasma Cell LeukemiaXue Li, Xin Guo, Yuqing Zhu, et al.
JAMA Oncology|April 17, 2025
Dasatinib and CAR T-Cell Therapy in Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Nonrandomized Clinical TrialMingming Zhang, Shan Fu, Jingjing Feng, et al.
Science Translational Medicine|February 25, 2021
Radiotherapy and immunotherapy converge on elimination of tumor-promoting erythroid progenitor cells through adaptive immunityYuzhu Hou, Hua L Liang, Xinshuang Yu, et al.
BMC Immunology|April 6, 2025
Prediction of Seronegative Hashimoto's thyroiditis using machine learning models based on ultrasound radiomics: a multicenter studyWenjun Wu, Shengsheng Yao, Daming Liu, et al.
JAMA Internal Medicine|November 3, 2025
Liraglutide in Acute Minor Ischemic Stroke or High-Risk Transient Ischemic Attack With Type 2 Diabetes: The LAMP Randomized Clinical TrialHuili Zhu, Bin Yang, Longyan Lu, et al.
American Journal of Hematology|September 20, 2023
Comparison of the prognostic predictive value of Molecular International Prognostic Scoring System and Revised International Prognostic Scoring System in patients undergoing allogeneic hematopoietic stem cell transplantation for myelodysplastic neoplasmsTingting Yang, Binqian Jiang, Yi Luo, et al.
Bone Marrow Transplantation|December 3, 2024
Better pre-transplant treatment options for TP53-mutated MDS: cytoreductive or non-cytoreductive therapy?Bingqian Jiang, Tingting Yang, Yanmin Zhao, et al.
Journal of Hematology & Oncology|May 6, 2020
Pre-transplant MRD negativity predicts favorable outcomes of CAR-T therapy followed by haploidentical HSCT for relapsed/refractory acute lymphoblastic leukemia: a multi-center retrospective studyHouli Zhao, Jieping Wei, Guoqing Wei, et al.
Pageof 46